A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration

PURPOSE: Azidothymidine (AZT), a nucleoside reverse transcriptase inhibitor, possesses anti-inflammatory and anti-angiogenic activity independent of its ability to inhibit reverse transcriptase. The aim of this study was to evaluate the efficacy of 5′-glucuronyl azidothymidine (GAZT), an antiretrovi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Invest Ophthalmol Vis Sci
Main Authors: Narendran, Siddharth, Pereira, Felipe, Yerramothu, Praveen, Apicella, Ivana, Wang, Shao-bin, Varshney, Akhil, Baker, Kirstie L., Marion, Kenneth M., Ambati, Meenakshi, Ambati, Vidya L., Ambati, Kameshwari, Sadda, Srinivas R., Gelfand, Bradley D., Ambati, Jayakrishna
Formato: Artigo
Idioma:Inglês
Publicado em: The Association for Research in Vision and Ophthalmology 2020
Assuntos:
Retina
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441363/
https://ncbi.nlm.nih.gov/pubmed/32749462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.61.10.4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados